Brachial-radial Pressure Gradient Phenomenon in Critically Ill Patients Treated With Vasoactive Agents
NCT ID: NCT07061457
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2025-04-14
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. What is the frequency of brachial-to-radial gradient in critically-ill patients receiving vasoactive agents?
2. Is brachial-to-radial gradient greater in patients receiving high doses of vasoactive agents?
3. Is brachial-to-radial gradient associated with worse peripheral perfusion?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II.
NCT06539234
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
NCT05529147
Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
NCT00518479
Impact of Citrulline and Arginine Supplementation on the Post-exercise Hypotension (PEH)
NCT03378596
Mean Systemic Filling Pressure Continuous Diuretics Critical Care Patients
NCT03395951
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult critically-ill patients receiving vasoactive agents
Adult critically-ill patients receiving vasoactive agents and undergoing invasive blood pressure monitoring in the radial artery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must be after initial resuscitation
* invasive blood pressure monitoring in the radial artery
* need for vasoactive drug therapy
Exclusion Criteria
* pressure transduction across invasive blood pressure circuit deemed to be inadequate
* mechanical circulatory support
* inability to match non-invasive cuff size to the patient's arm
* need for any hemodynamic intervention during performing study's measurements
* patient's decline to have the measurements done
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wojciech Szczeklik
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zbigniew Putowski, MD PhD
Role: STUDY_CHAIR
Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Cracow, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
5 Szpital Wojskowy z PoliklinikÄ… w Krakowie
Krakow, , Poland
Uniwersytecki Szpital w Opolu
Opole, , Poland
Uniwersyteckie Centrum Kliniczne w Warszawie
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
118.0043.1.305.2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.